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Abstract
Human neonates are highly susceptible to infection, which may be due in part to impaired innate immune function.
Neonatal Toll-like receptor (TLR) responses are biased against the generation of pro-inflammatory/Th1-polarizing cytokines,
yet the underlying mechanisms are incompletely defined. Here, we demonstrate that neonatal plasma polarizes TLR4-
mediated cytokine production. When exposed to cord blood plasma, mononuclear cells (MCs) produced significantly lower
TLR4-mediated IL-12p70 and higher IL-10 compared to MC exposed to adult plasma. Suppression by neonatal plasma of
TLR4-mediated IL-12p70 production, but not induction of TLR4-mediated IL-10 production, was maintained up to the age of
1 month. Cord blood plasma conferred a similar pattern of MC cytokine responses to TLR3 and TLR8 agonists,
demonstrating activity towards both MyD88-dependent and MyD88-independent agonists. The factor causing increased
TLR4-mediated IL-10 production by cord blood plasma was heat-labile, lost after protein depletion and independent of
lipoprotein binding protein (LBP) or soluble CD14 (sCD14). The factor causing inhibition of TLR4-mediated IL-12p70
production by cord blood plasma was resistant to heat inactivation or protein depletion and was independent of IL-10,
vitamin D and prostaglandin E2. In conclusion, human neonatal plasma contains at least two distinct factors that suppress
TLR4-mediated IL-12p70 production or induce IL-10 or production. Further identification of these factors will provide insight
into the ontogeny of innate immune development and might identify novel targets for the prevention and treatment of
neonatal infection.
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Introduction
Toll-like receptors (TLRs) are key pathogen recognition
receptors of the innate immune system that recognize highly
conserved structures expressed by micro-organisms, called path-
ogen-associated molecular patterns (PAMPs) [1]. TLR-mediated
recognition of microbial products or endogenous ‘‘danger’’ signals
results in production of cytokines and chemokines that initiate the
innate immune response and instruct the adaptive immune system
[2]. The balance between the production of pro- and anti-
inflammatory cytokines is tightly regulated, presumably to allow
efficient immune responses while protecting the host from
excessive inflammation [3]. Birth imposes major challenges on
the regulatory capacity of the immune system, including
prevention of harmful allo-immune reactions to maternal antigens
in utero, and balancing the transition from a sterile intra-uterine
environment to the microbe-rich outside world [4]. To face these
demands, neonatal TLR responses are physiologically biased
against the production of pro-inflammatory cytokines [5–7].
However, this bias leaves the newborn highly susceptible to
infections [8]. Recent studies indicate that despite impaired
production of Th1-type cytokines, the neonatal TLR system is
not generally depressed. In fact, neonatal innate immune cells,
including monocytes and dendritic cells (DC), demonstrate
increased TLR-mediated production of certain cytokines (IL-10,
IL-23) [9–13]. Together, this suggests the existence of regulatory
mechanisms that actively polarize the neonatal TLR system
towards decreased production of Th1-polarizing cytokines while
Th2- and Th17-polarizing responses are relatively preserved.
Insight into the mechanisms underlying this polarization is of great
interest, as a biological phenomenon and to identify potential
targets for the prevention and treatment of neonatal infections.
Despite many studies describing impaired TLR-mediated
production of Th1-polarizing cytokines by cord blood innate
immune cells [12–16], the underlying mechanisms are incom-
pletely characterized [9,13,17,18]. In addition, it is as yet unclear
whether the mechanisms that suppress Th1-polarizing cytokine
production in cord blood extend into the neonatal and infant age.
We have previously demonstrated that whole blood TLR4-
mediated cytokine responses at birth and at the age of one month
are distinct from adult responses and characterized by decreased
production of IL-12p70 and increased production of IL-10 [14].
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e33419In the current study, we aimed to determine whether soluble
factors in neonatal plasma contribute to distinct neonatal TLR4-
mediated production of IL-12p70 and IL-10.
Materials and Methods
Ethics statement
The research protocol was approved by the Medical Ethics
Committee of the University Medical Centre Utrecht and written
informed consent was obtained from parents of all participants.
Blood
Blood was obtained from healthy newborns participating in an
ongoing birth cohort study on the role of neonatal TLR responses
in the pathogenesis of respiratory tract infections and asthma [14].
Cord blood was collected immediately after uncomplicated term
vaginal delivery, but before delivery of the placenta. Neonatal
venous blood was collected from healthy newborns at the age of
one month (4–7 weeks, here referred to as ‘neonate’) and adult
blood was obtained from healthy volunteers. None of the
participants had signs or symptoms of infectious disease, such as
respiratory tract complaints or fever, in the two weeks prior to
sampling. Blood was collected in sterile, heparin-coated collection
tubes (BD Biosciences, Franklin Lakes, NJ). Plasma was prepared
within 24 h from blood collection via centrifugation (1000 g,
10 min, room temperature), aliquoted into cryovials (Nalge Nunc
International, Rochester, NJ) and stored at 220uC prior to use.
Pilot experiments demonstrated that times between blood
harvesting and plasma preparation from 0 up to 48 h did not
affect the modulatory effect of plasma on TLR4-mediated IL-
12p70 or IL-10 production (data not shown). MCs were isolated
and stimulated immediately after blood collection.
Immune agonists
In vitro stimulation was performed using optimal concentrations
of immune agonists and incubation times for cytokine measure-
ments, as titrated in pilot experiments (data not shown).
Accordingly, adult peripheral blood mononuclear cells (PBMCs)
or cord blood mononuclear cells (CBMCs) were stimulated with
polyinosinic:polycytidylic acid (poly I:C; 200 mg/mL; Invivogen,
San Diego, CA), ultrapure LPS from E. Coli (100 ng/mL;
InvivoGen), or CL-075 (10 mg/mL, InvivoGen). In cultures using
LPS only, no detectable IL-12p70 production was observed.
Therefore, for co-stimulation, recombinant IFN-c was used
(20 ng/mL; PeproTech Inc, Rocky Hill, NJ). Addition of IFN- c
did not influence the differential modulation of TLR4-mediated
IL-12p70 and IL-10 production by neonatal and adult plasma.
Stimulation with IFN- c only (i.e. without LPS) did not induce any
IL-10, IL-12p70 or IL-12p40 in any of the experiments performed
(data not shown).
Cell isolation and stimulation
Adult PBMCs and CMBCs were obtained by Ficoll-Hypaque
(Amersham Pharmacia Biotech, Uppsala, Sweden) gradient
separation. Cells were washed twice in sterile PBS and seeded in
96-well polystyrene culture plates (Nalge Nunc International,
Rochester, NJ) at 1610
6/mL in RPMI medium containing 2.5 g/
L D-glucose, 1.5 g/L sodium bicarbonate, 1 mM sodium
pyruvate, 10 mM HEPES and 300 mg/L L-glutamine (Invitro-
gen, Breda, NL). MCs were pre-incubated for 30 minutes in
plasma prior to addition of TLR agonists. After 24 h incubation at
37uC and 5% CO2, supernatants were collected for ELISA, or
cells were collected for intracellular cytokine staining. Unless
stated otherwise, experiments were performed in 10% plasma.
Cytokine measurement
Concentrations of IL-12p70 and IL-10 in culture supernatants
were determined by ELISA according to manufacturer’s instruc-
tions (eBioscience, San Diego, CA). Intracellular IL-12p40
production was detected by flow cytometry, using monoclonal
antibodies directed against CD14, CD3, CD56, CD16, HLA-DR
or, IL-12p40. Intracellular cytokine staining was performed
according to manufacturer’s protocol, using Golgi-stop to prevent
cytokine secretion [19]. Isotype controls were used to correct for
non-specific staining. A detailed description of antibody (source,
clone, dilution) machine set up, and data acquisition compliant
with the MiFlowCyt reporting standards [20] can be found in
text S1.
Plasma heat-inactivation and protein depletion
To characterize the plasma factor responsible for impaired
neonatal TLR responses, several approaches were used. Heat-
inactivation was performed by heating plasma for 30 min at 56uC.
To deplete plasma proteins, plasma was diluted 2-fold in serum-
free RPMI medium and boiled for 10 min at 100uC. Afterwards,
set precipitate was removed by centrifugation at 13000 g for
10 min. To ensure complete depletion/denaturation of plasma
proteins, the supernatant was subjected to another cycle of
boiling and centrifugation. Efficacy of protein depletion was
verified by BCA assay (Pierce, Rockford, IL). As plasma contains
several proteins that are needed for LPS-induced cytokine
release, all experiments using heat-inactivated or protein-
depleted or modified plasma were performed on a background
of 5% fetal calf serum (FCS). Addition of FCS up to a
concentration of 20% did not affect the differential modulation
of LPS-induced cytokine release between cord blood and adult
plasma (data not shown).
IL-10, PGE2, vitamin D, sCD14 and LBP
To determine the role of IL-10 as a mediator of TLR4-
mediated IL-12p70 production by cord blood plasma, we blocked
IL-10 by incubating plasma for 30 min in anti-IL-10 antibody
(1 mg/mL, EBioscience, clone JES3-9D7) or isotype control
(eBioscience), prior to running the in vitro stimulation assay. The
effect of PGE2 and 1,25-dihydroxy vitamin D (1,25-OHD) on
TLR4-mediated cytokine responses was assessed by determining
IL-12p70 and IL-10 production in presence of 10% FCS
supplemented with recombinant PGE2 or 1,25-OHD (both
obtained from Sigma Aldrich, Zwijndrecht, The Netherlands).
Plasma concentrations of PGE2 were measured by ultra sensitive
enzyme immunoassay according to manufacturer’s instructions
(Cayman Chemical, Ann Arbor, MI). Plasma concentrations of
25-OHD (the stable form of vitamin D) were measured with the
Modular E170 analyzer (Roche) [21]. Plasma concentrations of
sCD14 and LBP were measured by competitive binding assay,
according to manufacturer’s instructions (Hycult Biotech, Uden,
The Netherlands).
Statistical analyses
Comparisons were made using the Student’s t-test. When
multiple groups were compared (e.g. age-dependent effects of
plasma on TLR4-mediated cytokine responses, concentrations of
PGE2), one-way ANOVA with post-hoc Bonferroni correction was
used. Correlations between TLR4-mediated intracellular IL-
12p40 MFI and concentrations of IL-12p70 in culture supernatant
and between IL-12p70 production and plasma PGE2 concentra-
tion were assessed by Pearson correlation. All p-values are two-
sided and were considered significant if p,0.05.
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Differences in TLR4-mediated cytokine production
between neonates and adults are due to cellular and
soluble factors
We and others have previously reported that neonatal TLR
responses are distinct from adult responses [5,11,14], and that
distinct neonatal TLR4-mediated production of IL-12p70 and IL-
10 persists up until the age of one month [14]. To determine
whether decreased neonatal TLR4-mediated production of IL-
12p70 and increased production of IL-10 are due to differences in
the cellular or soluble fraction of the blood, we isolated CBMCs and
adult PBMCs, resuspended them to equivalent concentrations
(1610
6)andstimulated themwith LPSinthepresence ofcord blood
plasma or adult plasma (Fig. 1). CMBC produced no IL-12p70,
independent of the source of plasma(Fig. 1A). Adult PBMCs readily
produced IL-12p70, but only when stimulated in the presence of
adult plasma, indicating that TLR4-mediated IL-12p70 production
is modulated by soluble factors in plasma. TLR4-mediated
production of IL-10 by CBMC was also lower than production by
PBMC (Fig. 1B). Interestingly, the source of plasma significantly
influenced IL-10 production, with increased production in the
presence of cord blood plasma by both CBMC and adult PBMC.
Together, these findings demonstrate that the differences in whole
blood TLR4-mediated production of IL-12p70 and IL-10 between
neonates and adults are due to differences in both the cellular and
the soluble fraction of the blood.
To further explore modulation of TLR4-mediated cytokine
production by soluble factors in plasma, we stimulated PBMCs
from twenty (IL-12p70) or sixteen (IL-10) different adult donors in
the presence of adult or cord blood plasma (Fig. 1B). Cord blood
plasma suppressed TLR4-mediated IL-12p70 production in 18/20
(90%) of PBMC donors (p=0.0002) and TLR4-mediated IL-10
production was induced by cord blood plasma in 15/16 (94%) of
PBMR donors (p=0.0005).
Potential explanations for the differential modulation of TLR4-
mediated cytokine production by cord blood plasma and adult
plasma include the lack of factor(s) in cord blood plasma that
stimulate LPS+IFN-c-induced IL-12p70 production (and inhibit
IL-10), or the presence of factor(s) that inhibit IL-12p70 (and
induce IL-10). To distinguish these possibilities, we added
increasing concentrations of cord blood or adult plasma to PBMC
cultured in 5% FCS. Addition of either cord blood or adult plasma
dose-dependently inhibited TLR4-mediated IL-12p70, while
increasing TLR4-mediated IL-10 (Fig. 1C). Inhibition of TLR4-
mediated IL-12p70 and induction of IL-10 were more pronounced
in the presence of cord blood plasma, with statistically significant
stronger polarization of TLR4-mediated cytokine responses
compared to adult plasma across plasma concentrations of 1–
50% (v/v). Differential modulation of TLR4-mediated IL-12p70
and IL-10 production by cord blood plasma and adult plasma was
maintained in the presence of up to 20% FCS (data not shown).
These results indicate that human plasma contains one or multiple
factors that inhibit TLR4-mediated production of IL-12p70 and/
or induce production of IL-10. In addition, they demonstrate that
these factors are present at increased concentrations in cord blood
plasma.
Suppression of TLR4-mediated IL-12p70, but not
induction of IL-10, by neonatal plasma persists up to the
age of one month
We have previously shown that neonatal whole blood TLR4-
mediated cytokine responses are biased towards low IL-12p70 and
high IL-10 throughout the first month of life [14]. To determine
whether modulation of TLR4-mediated responses by plasma
contributes to distinct neonatal cytokine production at the age of
one month, we determined TLR4-mediated production of IL-
12p70 and IL-10 by adult PBMC stimulated in the presence of
plasma derived from cord blood, from healthy neonates aged one
month or from adult volunteers. Results showed similar patterns to
those previously observed in whole blood (Fig. 2) [14]. TLR4-
mediated production of IL-12p70 was significantly decreased in
the presence of both cord blood plasma and neonatal plasma
obtained at the age of one month compared to adult plasma across
plasma concentrations of 1–20% plasma (Fig. 2A). In contrast,
TLR4-mediated IL-10 production in presence of plasma of one
month old neonates was significantly reduced compared to cord
blood plasma and not statistically different from IL-10 production
in presence of adult plasma (Fig. 2B). This suggests that TLR4-
mediated IL-12p70 and IL-10 are regulated through distinct
plasma factors that are differentially present throughout the first
month of life.
Cord blood plasma suppresses TLR4-mediated IL-12p40
production by primary monocytes
Next, we aimed to identify the cell type(s) responsive for the
suppressive effect of neonatal plasma on TLR4-mediated IL-12
production by flow cytometry (Fig. 3). Stimulation with LPS+IFN-
c resulted in a strong IL-12p40-positive population (Fig. S1).
Among PBMCs, monocytes and mDC were the main producers of
TLR4-mediated IL-12p40, accounting for (mean 6 SEM)
62.261.9 and 22.061.8% of IL-12p40 positive cells, respectively
(Fig. 3A). Cord blood plasma conferred decreased production
of TLR4-mediated IL-12p40 (assessed by mean fluorescent
intensity, MFI) by monocytes, but not by mDC (Fig. 3B–C).
Although we were unable to detect any IL-12p35, there was a
strong correlation (R=0.75, p,0.01) between the effects of
individual plasma samples on monocyte IL-12p40 MFI and
PBMC-mediated production of IL-12p70 (Fig. 3D), suggesting
that monocyte intracellular IL-12p40 is a reliable marker for
extracellular IL-12p70 release. These findings confirm that the
majority of TLR4-mediated IL-12p70 is produced by monocytes.
Furthermore, they indicate that cord blood plasma suppresses
TLR4-mediated IL-12p70 via suppression of monocyte IL-12p40
production.
Cord blood plasma modulates TLR4-mediated cytokine
production through MyD88-dependent and MyD88-
independent pathways
Among TLRs, TLR4 is unique in its capacity to signal through
both MyD88-dependent and MyD88-independent pathways [2].
To determine whether one of these pathways is differentially
affected by plasma, we determined the effects of cord blood plasma
and adult plasma on responses to TLR3, which signals through
MyD88-independent/TRIF dependent pathways, and TLR8,
which signals MyD88-dependently (Fig. 4). Cord blood plasma
significantly suppressed IL-12p70 production to both agonists
(Fig. 4A), while increasing the production of IL-10 (Fig. 4B). This
indicates that cord blood plasma polarizes TLR-mediated cytokine
production through MyD88-dependent and through MyD88-
independent pathways.
To exclude the possibility that suppression of IL-12p70 by cord
blood plasma was secondary to increased basal concentrations of
IL-10 or to its increased release, we stimulated PBMC in presence
of IL-10 neutralizing antibody. Addition of 1 ug/ml IL-10-
neutralizing antibody increased TLR4-mediated IL-12p70 pro-
Neonatal Plasma Polarizes TLR4-Mediated Responses
PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e33419Figure 1. Human plasma suppresses TLR4-mediated production of IL-12p70 while inducing IL-10. A; TLR4-mediated release of IL-12p70
and IL-10 by cord blood mononuclear cells (CBMC) or adult peripheral blood mononuclear cells (PBMC) stimulated in the presence of 10% cord blood
plasma or adult plasma. Bars represent mean+SEM of five independent cord blood or adult plasma donors. B; TLR4-mediated release of IL-12p70 and
IL-10 by PBMC from three different adult donors stimulated in the presence of 10% cord blood plasma or adult plasma. C; Dose-response curves
showing TLR4-mediated release of IL-12p70 and IL-10 by adult PBMC in the presence of increasing concentrations of cord blood plasma or adult
plasma. Each dot represents mean 6 SEM of five independent cord blood or adult plasma donors. Data are representative of three independent
experiments. *; p,0.05, **; p,0.01.
doi:10.1371/journal.pone.0033419.g001
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PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e33419Figure 2. Suppression of TLR4-mediated IL-12p70, but not induction of IL-10, by neonatal plasma is maintained up until the age of
one month. Adult PBMC were stimulated with LPS (100 ng/mL) and IFN-c (20 ng/mL) in the presence of plasma derived from cord blood, healthy
newborns aged one month, or adult volunteers. After 24 h incubation, supernatants were collected and concentrations of IL-12p70 (A) and IL-10 (B)
were determined by ELISA. Bars represent mean+SEM of three to five different plasma samples. a; p,0.05 cord blood vs neonatal plasma, *; p,0.05
neonatal vs adult plasma, &; p,0.05 cord blood vs adult plasma.
doi:10.1371/journal.pone.0033419.g002
Figure 3. Cord blood plasma suppresses TLR4-mediated IL-12p40 production by primary monocytes. Adult PBMC were stimulated with
LPS (100 ng/mL) and IFN-c (20 ng/mL) in the presence of 10% cord blood plasma or adult plasma. After 24 hours, intracellular levels of IL-12p40 in
monocytes (CD14+/HLA-DR+), myeloid dendritic cells (mDC, CD32/CD162/CD562/CD142/HLA-DR+/CD11c+) and B-cells (CD32/CD162/CD562/
CD19+) were determined by flow cytometry. A; Proportion of monocytes, mDC and B-cells among the total population of IL-12p40
+ cells. Bars
represent means of five different plasma samples. B; Representative histograms of monocyte IL-12p40 production upon TLR4-stimulation in the
presence of cord blood plasma or adult plasma. C; Mean fluorescence intensity (MFI) of IL-12p40 in monocytes and mDC upon TLR4-stimulation in
the presence of cord blood plasma or adult plasma. Each dot represents one individual plasma sample. D; Correlation between TLR4-mediated
monocyte IL-12p40 MFI and IL-12p70 protein production by PBMC. Each dot represents one individual plasma sample. All data are representative of
three independent experiments. *; p,0.05.
doi:10.1371/journal.pone.0033419.g003
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Increased concentrations of anti-IL-10 antibody to 5 ug/ml did
not further enhance IL-12p70 production (Fig. S2), indicating that
all biologically active IL-10 was effectively inhibited. Inhibition of
IL-10 signalling failed to neutralize the difference between cord
blood and adult plasma, indicating that suppression of IL-12p70
by cord blood plasma is not mediated via IL-10.
Plasma regulates TLR4-mediated production of IL-12p70
and IL-10 through distinct factors
We next aimed to characterize the factor(s) responsible for the
polarization of TLR4-mediated cytokine production by cord blood
plasma. When assessing the stability of this/these factor(s), we
found that heat-inactivation differentially affected TLR4-mediated
production of IL-12p70 and IL-10 (Fig. 5). While heat-inactivation
did not affect plasma-mediated suppression of IL-12p70 produc-
tion (Fig. 5A), the differential effect of cord blood plasma and adult
plasma on TLR4-mediated IL-10 production disappeared
(Fig. 5B). To investigate whether the factor suppressing TLR4-
mediated IL-12p70 production is a protein, we depleted plasma
proteins by repetitive boiling. This approach resulted in a robust
reduction of plasma protein content (mean 6 SEM;
59.263.7 mg/mL vs 7.860.3 mg/mL, p,0.0001)(Fig. 5C) and
eliminated the induction of TLR4-mediated IL-10 by cord blood
plasma (Fig. 5E). However, protein-depletion of plasma did not
abrogate the differential effect of cord blood plasma and adult
plasma on TLR4-mediated IL-12p70 production (Fig. 5D). This
confirms regulation of TLR4-mediated cytokine production by
distinct heat-stable (IL-12p70) and heat labile (IL-10) factors in
plasma. Furthermore, failure of protein-depletion to neutralize the
differential effect of cord blood plasma and adult plasma on
TLR4-mediated IL-12p70 production (Fig. 5D) indicates that the
IL-12p70 suppressive factor(s) in cord blood plasma is not a
protein.
The cord blood plasma factors modulating TLR4-
mediated IL-12p70 and IL-10 are not PGE2, vitamin D,
soluble CD14 or LBP
We next aimed to further characterize the factors in neonatal
plasma that cause decreased production of TLR4-mediated IL-
12p70 and increased IL-10. Vitamin D and PGE2 are lipid
molecules present in plasma that are known to have IL-12p70
suppressive potential [22,23]. Indeed, 1,25-OHD (the active form
of vitamin D) dose-dependently suppressed TLR4-mediated IL-
12p70 production by PBMC (Fig. 6A). At high concentrations,
1,25-OHD also suppressed IL-10 production compared to vehicle
control (Fig. S3). However, concentrations of 25-OHD were
similar in cord blood plasma and adult plasma (Fig. 6B), suggesting
that suppression of TLR4-mediated IL-12p70 by cord blood
plasma is not mediated by vitamin D. Similarly, PGE2 conferred
dose-dependent inhibition of TLR4-mediated IL-12p70 produc-
tion and at high concentrations, stimulated TLR4-mediated IL-10
Figure 4. Cord blood plasma polarizes cytokine responses to MyD88-dependent and independent TLR agonists. A–B; Agonist-induced
production of IL-12p70 (A) and IL-10 (B) by adult PBMC stimulated in the presence of 10% cord blood plasma or adult plasma. PBMC were stimulated
for 24 h with medium, poly I:C (TLR3, 200 mg/mL) or CL-075 (TLR8, 10 mg/mL). After 24 h, supernatants were collected and cytokine concentrations
were determined by ELISA. Bars represent mean+ SEM from five different plasma samples. C; TLR4-mediated production of IL-12p70 by adult PBMC
stimulated in the presence of 10% cord blood plasma or adult plasma, with or without IL-10 neutralizing antibody (1 mg/mL). Each dot represents one
individual plasma sample. Data are representative of three independent experiments. *; p,0.05, **; p,0.01.
doi:10.1371/journal.pone.0033419.g004
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observed for concentrations physiologically present in plasma [24],
suggesting that plasma PGE2 might contribute to suppression of
TLR4-mediated IL-12p70 production. However, concentrations
of PGE2 were elevated in cord blood plasma, but not in plasma
from neonates at the age of one month compared to adult plasma
(mean 6 SEM; 29216534 pg/mL; 3696105 pg/mL and
469678 pg/mL, respectively, p,0.001) (Fig. 6D). In addition,
there was no correlation between PGE2 concentrations in
individual adult plasma samples and suppression of TLR4-
mediated IL-12p70 production (R=20.02, p=0.84) (Fig. 6E).
Because no TLR4-mediated IL-12p70 was produced in presence
of cord blood plasma or plasma from neonates aged one month,
no correlations with plasma PGE2 concentrations could be
calculated for these age groups. Together, these data suggest that
PGE2 is not the major cord blood plasma factor causing
exaggerated suppression of TLR4-mediated IL-12p70 production
over adult plasma.
Figure 5. Cord blood plasma modulates TLR4-mediated production of IL-12p70 and IL-10 via distinct factors. A–B; TLR4-mediated
production of IL-12p70 (A) and IL-10 (B) by adult PBMC stimulated in the presence of heat-inactivated plasma (30 min at 56uC) or control plasma. C–E;
Effect of protein-depleted plasma on TLR4-mediated cytokine responses. Plasma proteins were depleted by two consecutive cycles of boiling and
centrifugation and protein concentrations were measured by BCA protein assay (C). Adult PBMC were stimulated with LPS (100 ng/mL) and IFN-c
(20 ng/mL) in the presence of protein-depleted plasma or control plasma, and production of IL-12p70 (D) or IL-10 (E) were measured by ELISA. Each
dot represents one individual plasma sample. All data are representative of at least three individual experiments. *; p,0.05, **; p,0.01, ***; p,0.001.
doi:10.1371/journal.pone.0033419.g005
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PLoS ONE | www.plosone.org 7 March 2012 | Volume 7 | Issue 3 | e33419Figure 6. Suppression of TLR4-mediated IL-12p70 and induction of IL-10 by neonatal plasma are not due to prostaglandin E2,
vitamin D, soluble CD14 or LBP. A; TLR4-mediated production of IL-12p70 by adult PBMC stimulated in the presence of increasing concentrations
of 1,25-dihydroxyvitamin D (1,25-OHD). B; Concentrations of 25-hydroxyvitamin D (25-OHD) in cord blood plasma and adult plasma, determined by
EIA. C;, TLR4-mediated production of IL-12p70 by adult PBMC stimulated in the presence of increasing concentrations of prostaglandin E2 (PGE2). D;,
Concentrations of PGE2 in cord blood plasma and adult plasma. E;, Correlation between plasma concentration of PGE2 and its capacity to suppress
TLR4-mediated IL-12p70 production. F–G; Concentrations of LBP (F) and sCD14 (G) in cord blood plasma and adult plasma. Data are presented as the
mean 6 SEM of five to eight individual plasma donors and are representative of three independent experiments. In panel E, each dot represents one
individual plasma donor. *; p,0.05, **; p,0.01; ***; p,0.001.
doi:10.1371/journal.pone.0033419.g006
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PLoS ONE | www.plosone.org 8 March 2012 | Volume 7 | Issue 3 | e33419LBP and sCD14 are highly abundant plasma proteins that
support cytokine responses (including IL-10) by TLR4 [25]. We
hypothesized that increased concentrations of these proteins in
neonatal plasma might be responsible for increased TLR4-
mediated IL-10 production. However, concentrations of LBP
were similar between cord, neonatal and adult plasma (Fig. 6F)
and concentrations of sCD14 were even decreased in cord and
neonatal plasma compared to adult plasma (Fig. 6G). In addition,
we did not observe any correlation between concentrations of LBP
or sCD14 and TLR4-mediated IL-10 production (data not
shown). Therefore, LBP and sCD14 are not the proteins that
cause enhanced TLR4-mediated production of IL-10 in presence
of neonatal plasma compared to adult plasma.
Discussion
Despite increasing awareness of the importance of the TLR
system in the neonatal defence against infections [4], much
remains to be learned about the mechanisms regulating neonatal
TLR responses. Here, we demonstrate that cord blood plasma
polarizes TLR-mediated cytokine responses towards low produc-
tion of IL-12p70 and high production of IL-10. We show that this
polarizing effect is present throughout the first month of life,
thereby potentially contributing to high neonatal susceptibility to
infection. Although to a lesser extent, adult plasma also inhibited
TLR4-mediated IL-12p70 production and induced IL-10 produc-
tion, suggesting that human plasma is a physiologic regulator of
TLR responses throughout life.
The strength of our model, namely the use of multiple plasmas
per mononuclear cell donor, allowed us to analyze the effect of
plasma on TLR responses while eliminating any contribution of
cellular differences between neonates and adults. Of note, only
adult PBMC (but not CBMC) in the presence of adult plasma were
capable of producing IL-12p70 (Fig. 1A), indicating that in
addition to the pivotal soluble plasma factors, cellular factors also
contribute to the difference in TLR-mediated IL-12 production
between neonates and adults.
Previous studies have identified multiple cellular mechanisms
that account for different TLR responses between neonates and
adults. An elegant study by Goriely et al. demonstrate that
decreased TLR4-mediated IL-12p70 production by cord blood
dendritic cells is due to impaired nucleosome remodelling,
resulting in decreased accessibility of the IL-12p35 promoter
[17,26]. In addition, despite similar basal levels of CD14 [13],
neonatal monocytes might express lower levels of MyD88 [26,27],
and demonstrate lower TLR4-mediated p38 phosphorylation
[13].
In addition to cellular defects, the current study indicates that
differences in the soluble fraction of the blood play a pivotal role in
polarization of the neonatal TLR system against Th1-polarizing
responses.
Our results demonstrate that polarization of TLR4-mediated
cytokine responses by cord blood plasma is not due to a single
factor, but mediated by multiple distinct factors that suppress
production of IL-12p70 or induce production of IL-10 (Fig. 5). Its
resistance to heat-inactivation and protein depletion suggests that
the IL-12p70 suppressive factor in cord blood plasma is not a
protein. Several non-protein factors in plasma are known to
modulate responses by TLR4 and may be responsible for the
observed effects in our study.
First, vitamin D is an essential nutrient with multiple immune
modulatory functions, including inhibition of IL-12p70 production
by dendritic cells [22] and PBMC (Fig. 6). However, concentra-
tions of 25-OHD, the stable form of vitamin D, were similar in
cord blood plasma and adult plasma. Thus, although vitamin D
may contribute to suppression of TLR4-mediated IL-12p70 by
cord blood plasma and adult plasma, it is unlikely to account for
the enhanced suppression of TLR4-mediated IL-12p70 by cord
blood. Of note, we did not exclude the possibility that increased
neonatal conversion of 25-OHD to 1,25-OHD might result in
higher plasma concentrations of bioactive vitamin D and increased
suppression of TLR4-mediated IL-12p70 production [28].
Second, PGE2 is an important lipid mediator that can suppress
IL-12p70 production by LPS-stimulated dendritic cells [23]. In
figure 6, we confirm that PGE2 is a potent suppressor of TLR4-
mediated IL-12p70 which is present in increased concentrations in
cord blood plasma. However, the observation that PGE2
concentrations in plasma from neonates aged one month were
similar to adult levels, and the lack of correlation between
concentrations of PGE2 in individual plasma samples and the
extent to which they suppresses TLR4-mediated IL-12p70
production, suggests that PGE2 is not the major plasma factor
that suppresses neonatal TLR4-mediated IL-12p70 production.
In addition to vitamin D and PGE2, plasma contains many
other non-protein factors capable of suppressing TLR4-mediated
IL-12 production, including metabolites [29,30], polyunsaturated
fatty acids [31] and carbohydrate structures [32]. Selective
depletion and separation strategies are needed to identify factors
that suppress neonatal TLR4-mediated IL-12p70 production.
In contrast to suppression of TLR4-mediated IL-12p70
production, the factor in cord blood plasma that induces IL-10
is heat-labile and lost upon protein depletion (Fig. 5). A hallmark
example of heat-sensitive immune modulatory factors in plasma is
the complement family. Although multiple studies have shown that
complement factors can suppress TLR-mediated production of
pro-inflammatory cytokines [33,34], their effect on IL-10 is still
subject of debate. Whereas C3b and C5a have increase IL-10
production in response to allergen [35] or TLR stimulation [36]
respectively, C1q suppresses IL-10 production by human DC [37].
Moreover, neonatal plasma concentrations of complement are
diminished, ranging from ,10–70% of adult levels [38,39]. Thus,
complement is unlikely to account for the enhanced induction of
TLR4-mediated IL-10 by cord blood plasma. Other plasma
factors capable of enhancing TLR4-mediated IL-10 production
include low-density lipoproteins [40], retinoic acid [41], and
adenosine [42]. The relative contribution of these and other
factors to induction of TLR4-mediated IL-10 by whole plasma will
require further investigations.
The suppression of TLR4-mediated Th1-polarizing responses
by neonatal plasma also has potential clinical applications.
Multiple plasma replacement strategies (e.g. dialysis, filtration)
are clinically approved for the treatment of neonatal kidney
failure. We hypothesize that plasma may provide a highly
interesting target for immune modulation strategies aimed at
treating neonatal infection.
In summary, we demonstrate that human newborn plasma
contains increased concentrations of distinct soluble factors that
suppress IL-12p70 or increase IL-10 production to various TLR
agonists, thereby potentially contributing to compromised neona-
tal innate immune responses. In addition, the concentration-
dependent polarization of TLR responses by adult plasma suggests
that plasma might contain multiple physiologic regulators of TLR
responses throughout life. Further identification of these plasma
factors and the mechanism by which they mediate their effect
might provide novel therapeutic targets to promote immune
responses in case of infection, to enhance responses to vaccination,
and to limit excessive inflammation in patients with auto-immune
disease.
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Figure S1 Flow cytometric detection of TLR4-mediated
IL-12p40. PBMC were stimulated for 4 h with LPS (100 ng/mL)
and IFN-c (20 ng/mL) in the presence of exocytosis inhibitor.
Intracellular IL-12p40 was determined by flow cytometry, as
described in text S1. Panels demonstrate intracellular IL-12p40 by
PBMC, in unstimulated control cultures, LPS+IFN-c stimulated
isotype control stainings, and in LPS+IFN- c stimulated IL-12p40
stained settings.
(TIF)
Figure S2 Antibody-mediated inhibition of IL-10. PBMC
were incubated with IL-10 blocking antibody (1 mg/mL or 5 mg/
mL) for 30 minutes, and subsequently stimulated with LPS+IFNc.
After 24 hours, culture supernatants were collected and concen-
trations of IL-12p70 were measured by ELISA. **; p,0.01.
(TIF)
Figure S3 Effect of vitamin D and PGE2 on TLR-4
mediated production of IL-10. TLR4-mediated production of
IL-10 by adult PBMC stimulated in the presence of increasing
concentrations of 1,25-dihydroxyvitamin D (1,25-OHD, panel A),
or PGE2 (panel B). *; p,0.05, **; p,0.01.
(TIF)
Text S1 MIFlowCyt standard compliant information for
submitted flow cytometric data.
(DOC)
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